Markets:

Overview

News

Currencies

International

Treasuries

Emergent BioSolutions Inc. Common Stock (NY:EBS)

7.390 +0.080 (+1.09%)

Streaming Delayed Price Updated: 3:28 PM EDT, Jul 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Emergent BioSolutions Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic

October 08, 2024

From Emergent BioSolutions

Via GlobeNewswire

What's Going On With Emergent BioSolutions Stock Wednesday? ↗

October 02, 2024

Emergent BioSolutions stock is trading higher after the company announced the closing of a $100 million asset-backed revolving loan facility.

Via Benzinga

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility

October 02, 2024

From Emergent BioSolutions

Via GlobeNewswire

(EBS) - Analyzing Emergent BioSolutions's Short Interest ↗

August 20, 2024

Via Benzinga

7 Analysts Assess Emergent BioSolutions: What You Need To Know ↗

August 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 26, 2024

Via Benzinga

Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts

September 26, 2024

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines ↗

September 25, 2024

Emergent BioSolutions secures $400M in orders for smallpox and mpox products, receives FDA approval for ACAM2000's expanded use, and updates its 2024 revenue forecast while beating Q2 sales estimates.

Via Benzinga

Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation

September 13, 2024

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts

September 25, 2024

$185+ million in incremental orders for ACAM2000® and VIGIV to be delivered in 2024 and 2025

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola

September 12, 2024

From Emergent BioSolutions

Via GlobeNewswire

Methanex, Merck And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

September 09, 2024

Via Benzinga

Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile

September 03, 2024

New favorable terms position Emergent for sustainable, long-term growth, as part of its multi-year plan to stabilize, turnaround and transform the company

From Emergent BioSolutions

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 02, 2024

Via Benzinga

Emergent BioSolutions Stock Storms Higher After The FDA Signs Off On Mpox Vaccine ↗

August 30, 2024

Emergent BioSolutions stock jumped early Friday.

Via Investor's Business Daily

Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness

August 30, 2024

From Emergent BioSolutions

Via GlobeNewswire

Mpox Vaccine: Emergent BioSolutions' Smallpox Vaccine Gets FDA Nod For Expanded Use For Individuals At High Risk Of Mpox Infection ↗

August 30, 2024

The FDA has approved Emergent BioSolutions' supplemental Biologics License Application for ACAM2000 to include the prevention of mpox disease in high-risk individuals, with the approval based on human...

Via Benzinga

Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

August 30, 2024

Via Benzinga

Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions

August 29, 2024

From Emergent BioSolutions

Via GlobeNewswire

WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped' ↗

August 26, 2024

To fight the mpox outbreak in Africa, the World Health Organization calls for funding help for its six-month plan.

Via Benzinga

Macy's Reports Weak Sales, Joins JD.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

August 21, 2024

Via Benzinga

Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals

August 20, 2024

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa

August 19, 2024

From Emergent BioSolutions

Via GlobeNewswire

3 Promising Vaccine Stocks To Watch In The Event Of A Mpox Surge ↗

August 19, 2024

Mpox rerun is making these stocks soar. But a non-vaccine approach could yield greater gains.

Via Talk Markets

Why Emergent BioSolutions Stock Is Skyrocketing Today ↗

August 16, 2024

Concerns about the mpox outbreak are causing Emergent BioSolutions' shares to jump.

Via The Motley Fool

H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday ↗

August 16, 2024

Via Benzinga

Why Greenland Technologies Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket ↗

August 16, 2024

Via Benzinga

Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On? ↗

August 15, 2024

Several healthcare stocks associated with mpox are seeing increased attention Thursday after the World Health Organization declared a public health emergency in response to an mpox outbreak in Africa.

Via Benzinga

Titan Machinery Reports Weak Preliminary Results, Joins Precigen, Gogoro And Other Big Stocks Moving Lower In Thursday Pre-Market Session ↗

August 15, 2024

Via Benzinga

WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak ↗

August 14, 2024

A public health emergency for mpox in Africa saw vaccine stocks jump Wednesday. A look at the stocks and what's next for fighting the virus.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.